Monoamine oxidase inhibitors (MAOI) could inhibit barbiturate metabolism and extend barbiturate effects; monitor intently

pentobarbital will lower the level or outcome of dutasteride by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Unknown.

pentobarbital decreases amounts of amphotericin B deoxycholate by inhibition of GI absorption. Applies only to oral method of both brokers. Minor/Significance Mysterious.

pentobarbital will minimize the level or impact of trazodone by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.

pentobarbital will minimize the extent or outcome of aprepitant by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.

pentobarbital will minimize the level or influence of ethinylestradiol by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Keep away from or Use Alternate Drug. The efficacy of hormonal contraceptives could be lessened. Use of a nonhormonal contraceptive is recommended.

pentobarbital will reduce the extent or result of methadone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.

pentobarbital will decrease the level or effect of atogepant by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Carefully. Encouraged atogepant dosage with concomitant utilization of sturdy or reasonable CYP3A4 inducers is 30 mg or 60 mg qDay.

pentobarbital will reduce the extent or influence of ripretinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism.

pentobarbital will decrease the extent or outcome of buprenorphine subdermal implant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Closely. Check people previously on buprenorphine subdermal implant who require newly-initiated treatment method with CYP3A4 inducer for signs and indicators of withdrawal.

pentobarbital will decrease the level or result nembutal pills of ixabepilone by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.

pentobarbital will lower the extent or influence of fruquintinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. If coadministration with reasonable CYP3A4 inducers is unavoidable, carry on to administer fruquintinib at recommended dosage.

pentobarbital improves toxicity of ifosfamide by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch. CYP3A4 inducers might raise the metabolism of ifosfamide to its Energetic alkylating metabolites.

pentobarbital will minimize the extent or impact of ethotoin by affecting hepatic enzyme CYP2C9/ten metabolism. Use Caution/Keep track of.